Compare · APD vs CDXS
APD vs CDXS
Side-by-side comparison of Air Products and Chemicals Inc. (APD) and Codexis Inc. (CDXS): market cap, price performance, sector, and recent activity on the wire.
Summary
- APD operates in Basic Materials, while CDXS operates in Industrials - the two are in different parts of the market.
- APD is the larger of the two at $65.83B, about 323.3x CDXS ($203.6M).
- Over the past year, APD is up 0.5% and CDXS is down 21.5% - APD leads by 21.9 points.
- APD has hit the wire 11 times in the past 4 weeks while CDXS has been quiet.
- APD has more recent analyst coverage (25 ratings vs 12 for CDXS).
- Company
- Air Products and Chemicals Inc.
- Codexis Inc.
- Price
- $295.52-0.56%
- $2.23+3.00%
- Market cap
- $65.83B
- $203.6M
- 1M return
- +5.37%
- -10.08%
- 1Y return
- +0.47%
- -21.48%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2010
- News (4w)
- 11
- 0
- Recent ratings
- 25
- 12
Air Products and Chemicals Inc.
Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and services worldwide. The company produces atmospheric gases, including oxygen, nitrogen, argon, and rare gases; process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, syngas, and specialty gases; and equipment for the production or processing of gases comprising air separation units and non-cryogenic generators for customers in various industries, including refining, chemical, gasification, metals, manufacturing, food and beverage, electronics, magnetic resonance imaging, energy production and refining, and metals. It also designs and manufactures equipment for air separation, hydrocarbon recovery and purification, natural gas liquefaction, and liquid helium and liquid hydrogen transport and storage. Air Products and Chemicals, Inc. has a strategic collaboration with Baker Hughes Company to develop hydrogen compression systems. The company was founded in 1940 and is headquartered in Allentown, Pennsylvania.
Codexis Inc.
Codexis, Inc. discovers, develops, and sells biocatalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
Latest APD
- Air Products to Broadcast Fiscal 2026 Third Quarter Earnings Teleconference on July 30, 2026
- SEC Form 4 filed by Director Stern Alfred
- SEC Form 4 filed by Director Ungerleider Howard I
- SEC Form 4 filed by Director Smith Wayne Thomas
- SEC Form 4 filed by Director Reilley Dennis H
- SEC Form 4 filed by Director Calaway Tonit M
- SEC Form 4 filed by Director Graziano Jessica
- SEC Form 4 filed by Director Evans Andrew W
- SEC Form 4 filed by Director Patel Bhavesh V.
- Air Products and Chemicals Inc. filed SEC Form 8-K: Material Impairments, Regulation FD Disclosure
Latest CDXS
- SEC Form 8-K filed by Codexis Inc.
- SEC Form 4 filed by Director Parker H Stewart
- SEC Form 4 filed by Director Collins Cynthia
- SEC Form 4 filed by Director Richards Christos
- SEC Form 4 filed by Director Smith David V
- SEC Form 4 filed by Director Singhvi Rahul
- SEC Form 4 filed by Director Martinborough Esther
- SEC Form 4 filed by Director Dilly Stephen George
- SEC Form 4 filed by Director De Vre Raymond
- Director De Vre Raymond sold $6,174 worth of shares (2,605 units at $2.37), decreasing direct ownership by 3% to 84,811 units (SEC Form 4)